"Novel neural biomarkers of mood disorder risk: replication, treatment targets and next steps"
VUMC Psychiatry and Behavioral Sciences
About the Speaker:
Mary L. Phillips, MD
Distinguished Professor in Psychiatry and Clinical and Translational Science Pittsburgh Foundation - Emmerling Endowed Chair in Psychotic Disorders Director, Center for Research in Translational & Developmental Affective Neuroscience
Department of Psychiatry, University of Pittsburgh
Objectives:
The activity is designed to help the learner:
1. To explain how measures of large scale neural network activity predict future risk of mania and depression
2. To describe research replicating predictive relationships among neural biomarkers and mania and depression risk
3. To demonstrate how these novel neural markers can be targeted by neuromodulation as a way forward to develop new treatments for mood disorders
Summary:
Dr. Phillips uses state-of-the-art brain imaging techniques to study biological processes underlying mood disorder risk. She has identified brain activity markers reflecting these processes to help improve early diagnosis and risk identification in youth and young adults; and targets these markers to develop novel brain stimulation treatments for mood disorders.
CME/CE credit for Psychiatry Grand Rounds is only available during the live feed time and for a brief time immediately following. The code for this week's session is displayed at the opening and closing of the meeting and also in the Chair's Office Account Name during the meeting.
For CME/CE information about this session, please visit:
Microsoft Teams
Join on your computer, mobile app or room device
Click here to join the meeting
Meeting ID: 238 474 167 446
Passcode: xSQJWu
This talk is sponsored by the
Luton Lecture Fund
Department of Psychiatry and Behavioral Sciences
This educational activity received no commercial support.